Dawn Kimball's Insider Trades & SAST Disclosures
Dawn Kimball's most recent trade in Lifecore Biomedical Inc was a trade of 13,608 Common Stock done at an average price of $12.1 . Disclosure was reported to the exchange on March 12, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dawn Kimball.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 12.09 per share. | 12 Mar 2021 | 13,608 | 18,608 (0%) | 0% | 12.1 | 164,521 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 13,608 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 12.09 per share. | 12 Mar 2021 | 13,608 | 15,964 (0%) | 0% | 12.1 | 164,521 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Sale or transfer of securities back to the company at price $ 12.09 per share. | 12 Mar 2021 | 6,535 | 9,429 (0%) | 0% | 12.1 | 79,008 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Sale or transfer of securities back to the company at price $ 12.09 per share. | 12 Mar 2021 | 6,453 | 9,679 (0%) | 0% | 12.1 | 78,017 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 12.09 per share. | 12 Mar 2021 | 5,000 | 5,000 (0%) | 0% | 12.1 | 60,450 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 5,000 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 12.09 per share. | 12 Mar 2021 | 5,000 | 5,000 (0%) | 0% | 12.1 | 60,450 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Sale or transfer of securities back to the company at price $ 12.09 per share. | 12 Mar 2021 | 2,644 | 2,356 (0%) | 0% | 12.1 | 31,966 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Sale or transfer of securities back to the company at price $ 12.09 per share. | 12 Mar 2021 | 2,476 | 16,132 (0%) | 0% | 12.1 | 29,935 | Common Stock |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 21,580 | 21,580 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | Dawn Kimball | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 9,920 | 9,920 | - | - | Non-Qualified Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges